| Front page | | Next |

Environmental Assessment of Veterinary Medicinal Products in Denmark

Contents

Preface
       
Summary
       
Dansk resumé
       
1. Introduction
1.1 Grouping of veterinary medicinal products in Denmark
1.2 Danish legislation on veterinary medicinal products
1.3 The structure of the report
       
2. Use, consumption and environmental release of veterinary medicinal products in Denmark
2.1 Quantification of the use of single substances
2.1.1 Drugs for the alimentary tract and metabolism (group QA), Table C.1
2.1.2 Hormones (group QG and QH), Table C.2
2.1.3 Antibiotics (group QJ01 and QJ51) , Table C.3
2.1.4 Drugs for the Central Nervous System (CNS) (group QN), Table C.4
2.1.5 Antiparasitic agents (group QP), Table C.5
2.1.6 Antimicrobial growth promoters (non-therapeutic use), Table C.6
2.1.7 Coccidiostatics used in poultry production, Table C.7
2.1.8 Veterinary medicine used as feed administrated drugs, Table C.8.
2.1.9 Summary of the use of veterinary medicinal products in Denmark.
2.2 Environmental Release
2.3 Summary and conclusions
       
3. Environmental fate and occurrence of Veterinary Medicinal Products
3.1 Pharmacological fate of veterinary medicines
3.2 Fate in the environment
3.2.1 Bioaccumulation
3.3 Occurrence in the environment
3.3.1 Measured environmental concentrations
3.3.2 Predicted Environmental Concentrations (PECs)
3.4 Summary and conclusions on fate and occurrence of veterinary medicines
       
4. Ecotoxicological effects of veterinary medicinal products
4.1 The aquatic environment
4.2 The terrestrial environment
4.3 Summary and conclusions on environmental effects of veterinary medicines
       
5. Legislation concerning environmental risk assessment of veterinary medicinal products
5.1 Introduction
5.2 ERA for new and existing substances in the EEC region
5.3 Comparison of ERA for veterinary medicinal products and food additives with ERA for new and existing substances in the EEC region
5.4 Phase 1
5.5 Phase II
5.5.1 Tier A
5.5.2 Tier B
5.6 Summary and conclusions
       
6. Conclusions
       
7. Recommendations
       
8. References
       
9. Appendix A - List of CAS and ATC codes for substances quantified.
       
10. Appendix B - Danish legislation
       
11. Appendix C. Quantification of the use of single substances.
       
12. Appendix D
       
13. Appendix E
       
14. Appendix F
       
15. Appendix G
       
16. Appendix H - Terminology and abbreviations       

 

| Front page | | Next | | Top |